Go Back
Held: October 15, 2016
View / Download Slides
Access Post Program Survey
Program Description:
The 2016 Botulinum Toxin Therapy Update: Focus on Limb Dysfunction is an interactive educational program with case-based presentations and workshops that provide a review of the mechanism of action, therapeutic rationale, and clinical application of botulinum neurotoxin in the management of limb dysfunction. This conference includes a live patient workshop for physicians and allied health care professionals on limb injections techniques as well as, a comprehensive review of upper and lower muscle anatomy with a cadaver lab. Participants will also have an opportunity to review ultrasound, EMG, and electrical stimulation guidance updates and the most recent billing and coding recommendations.
Target Audience:
The target audience for this live 7.5-Hour certified conference is neurologists, physiatrists, pain specialists, resident physicians, nurse practitioners, registered nurses, physician assistants, physical therapists and other allied health practitioners interested in learning more about botulinum toxin therapy.
Educational Objectives:
After completing this activity, the participant should be better able to:
- Discuss the mechanism of action and the conceptual basis for therapeutic botulinum neurotoxin therapy in patients with limb dysfunction
- Explain the anatomy of upper and lower limb muscles typically injected with botulinum toxin for the treatment of spasticity, dystonia, and pain.
- Review the current literature regarding the treatment of limb spasticity and pain in adults and children with botulinum toxin therapy
- Evaluate commercial preparations and application of botulinum neurotoxin in limb dysfunction
- Identify appropriate patients for botulinum neurotoxin therapy and determine appropriate injection-site-specific selection and dosing strategies
- Discuss the importance of post-injection follow-up and strategies to improve patient outcomes
- Select the proper billing and coding for botulinum toxin injections
Agenda:
Morning Sessions:
| 7:30am – 8:00am | Breakfast | |
| 8:00am – 8:15am | Welcome and Introductions | – Khashayar Dashtipour, MD, PhD |
| 8:15am – 8:45am | Scientific Update | – Laxman Bahroo, DO |
| 8:45am – 9:15am | Limb Dystonias | – Mark F. Lew, MD, FAAN, FANA |
| 9:15am – 9:45am | Splinting, Casting, and Physical Therapy | – Remy Chu Jr., MHA, OTR/L |
| 9:45am – 10:00am | Break | |
| 10:00am – 10:30am | Limb Pain (Tendonitis, Osteoarthritis, Plantar Fasciitis, Piriformis Syndrome) | – Martin Taylor, DO, PhD |
| 10:30am – 11:00am | Ultrasound, EMG, and Electrical Stimulation Guidance | – Katharine E. Alter, MD |
| 11:00am – 11:45am | Limb Spasticity in Children and Adults | – Allison Przekop, DO |
| 11:45am – 12:30pm | Working Lunch (Billing and Coding Update) | – Martin Taylor, DO, PhD |
Afternoon Sessions:
| 12:30pm – 1:00pm | Pre-Workshop Anatomy Overview | – Jamie Wikenheiser, MD |
| 1:10pm – 2:30pm | Injections and Anatomy Cadaver Lab Session 1 | |
| Group A: Patient Limb Injections | – Katharine E. Alter, MD – Ziyad Ayyoub, MD – Mindy K. Bixby, DO – Lynsey L. Taylor, MSN, FNP-C – Martin Taylor, DO, PhD |
|
| Group B: Anatomy Cadaver Lab | – Laxman Bahroo, DO – Khashayar Dashtipour, MD, PhD – Zackary Gallaher, PhD – Jamie Wikenheiser, MD |
|
| 2:40pm – 4:00pm | Injections and Anatomy Cadaver Lab Session 2 | |
| Group A: Anatomy Cadaver Lab | – Laxman Bahroo, DO – Khashayar Dashtipour, MD, PhD – Zackary Gallaher, PhD – Jamie Wikenheiser, MD |
|
| Group B: Patient Limb Injections | – Katharine E. Alter, MD – Ziyad Ayyoub, MD – Mindy K. Bixby, DO – Lynsey L. Taylor, MSN, FNP-C – Martin Taylor, DO, PhD |
|
| 4:10pm – 4:25pm | Closing Remarks | – Khashayar Dashtipour, MD, PhD |
Course Director:
Khashayar Dashtipour, MD, PhD
Associate Professor Neurology & Basic Sciences
Director, Division of Movement Disorders
Department of Neurology/Movement Disorders
Loma Linda University School of Medicine
Loma Linda, CA
Co-Director:
Martin Taylor, DO, PhD
Neurology / OrthoNeuro
Clinical Associate Professor, Neurology
Ohio University College of Osteopathic Medicine
Columbus, OH
Faculty:
Katharine E. Alter, MD
Physiatrist, Mount Washington Pediatric Hospital, Baltimore MD
Clinical Assistant Professor, PM&R
AT Still University, Mesa AZ
Ziyad Ayyoub, MD
Clinical Professor of PMR
Western University of Health Sciences
Paramount CA
Laxman Bahroo, DO
Director Botulinum Toxin Clinic
Director Neurology Residency Program
Associate Professor of Neurology
Georgetown University Hospital
Washington, DC
Mindy K. Bixby DO
Board Certified Neurologist
Movement Disorder Specialist
Neurorehabilitation Specialist
Laguna Hills, California
Remy Chu Jr., MHA, OTR/L
Occupational Therapy Clinical Manager
Tyler A. Dykes Center for Robotic Rehabilitation Program Manager
Rancho Los Amigos National Rehabilitation Center
County of Los Angeles
Department of Health Services
Los Angeles, CA
Zachary Gallaher, PhD
Postdoctoral Fellow
University of California, Irvine
Irvine, CA
Mark F. Lew, MD, FAAN, FANA
Professor of Neurology
Director Division of Movement Disorders
Vice-Chair Department of Neurology
Joseph P. VanDerMeulen Chair in PD Research
USC University of Southern California
In Honor of Robert Pasarow
Keck/USC School of Medicine
Los Angeles, CA
Allison Przekop, DO
Assistant Professor
Pediatrics, Division of Child Neurology
Loma Linda University Children’s Hospital
Loma Linda, CA
Lynsey L Taylor MSN, FNP-C
Neurology Nurse Practitioner
The Neurology Group
Pomona CA
Martin Taylor, DO, PhD
Neurology / OrthoNeuro
Clinical Associate Professor, Neurology
Ohio University College of Osteopathic Medicine
Columbus, OH
Jamie Wikenheiser, MD
Associate Professor
Director of Medical Gross Anatomy and Embryology
Director of Surgical Anatomy
Department of Anatomy and Neurobiology
University of California, Irvine School of Medicine
Irvine, CA
Registration Fee:
There is a $50 registration fee for this educational activity. A full refund will be provided for cancellations up to 14 days prior to the event.
Disclosure of Conflicts of Interest:
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager | Reported Financial Relationship |
| Margaret Clark | Nothing to disclose |
| Ashley Marostica, RN, MSN | Nothing to disclose |
| Amanda Glazar, PhD | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
Disclosure of Unlabeled Use:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accreditation:
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.
This educational activity for 7.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com
This activity is provided by Global Education Group.
Endorsements:
This activity is proudly endorsed by the North American Neurotoxin Association.
Support Statement:
This activity is supported by educational grants provided by Ipsen Biopharmaceuticals, Inc. and US WorldMeds LLC.
Sponsorship and Exhibit Opportunities:
SPONSORSHIP AND EXHIBIT INFORMATIONInstructions to Receive Credit:
In order to receive credit for this activity, the participant must complete the pre-assessment, post-assessment, evaluation, and then claim credit.